Novel drug prevents common viral disease in stem-cell transplant patients, study finds
A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham ...
Sep 25, 2013
0
0